Riko Maruyama

2PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 13, 2026
Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications.

|Mar 05, 2024
Treatment-related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib.

Riko Ikeda, Yoh Matsuoka, Masaharu Inoue

Pageof 1